Innovators, investors, academia, and entrepreneurs will come together to push the envelope on how we feed, fuel, heal, and build the world using synthetic biology.
Read MorePioneers of tech and biology will take the stage at synthetic biology's premier industry event Oct. 1-3 in San Francisco, joining leading innovators, investors, and entrepreneurs
Read MoreFuturists and other experts organized by The Millennium Project provide a coherent framework to understand global change and prospects for the future. Possibly the most comprehensive synthesis of future challenges - from AI, synthetic biology, robotics, and nanotech to work, terrorism, climate change, population, gender, global ethics, and the next economics - in clear, precise language.
Read MoreYale University iGEM Research Team garners silver award designation for research and development of synthetic biology workflows for studying non-model and environmentally significant microbes with the support of AmericanBio, Inc.
Read MoreTransparency Market Research Add New "Synthetic Biology Market, Global Industry Analysis, Size, Growth, Share and Forecast, 2012 - 2018" Market Research Report To It's a Database.
Read MoreSynpromics Ltd, the synthetic promoter company, announces the award by the Technology Strategy Board, the UK's innovation agency, of an over £240,000 grant; this is part of a £5.3 million injection to UK Biotech by the UK Government
Read MoreSince 2009, GenScript, as a leading company in the synthetic biology field, has continued sponsoring iGEM teams by providing superior quality gene synthesis service to facilitate the teams building novel biological systems.
Read MoreSynpromics is pleased to announce that Andrei Lyne has joined the company as Chief Financial Officer. The new appointment demonstrates Synpromics's commitment to build a world-class management team to fully exploit its innovative technology.
Read MoreSynpromics announces it incorporation as Scotland's latest biotech company. The new company aims to focus its activities in the area of synthetic mammalian biology and has acquired a number of patent applications submitted by Dr Michael Roberts.
Read More